What is Cost of Goods Sold (COGS)?

Cost of Goods Sold (COGS) represents the direct costs attributable to producing cannabis products that a company sells during a specific period. For cannabis companies, COGS includes cultivation expenses, processing costs, packaging materials, direct labor, and manufacturing overhead directly tied to production. In the cannabis industry, COGS calculation involves unique complexities due to regulatory requirements and varying state laws. Cultivation COGS typically includes seeds or clones, nutrients, soil, lighting, facility rent allocated to growing operations, and direct labor for cultivation activities. For processing companies, COGS encompasses raw cannabis flower purchases, extraction equipment depreciation, solvents, testing fees, and packaging materials. Cannabis companies often report COGS as a percentage of revenue, with industry benchmarks varying significantly. Multi-state operators (MSOs) typically report COGS ranging from 40-60% of revenue, while single-state operators may see higher percentages due to limited scale. For example, major MSOs like Curaleaf (CURLF) and Green Thumb Industries (GTBIF) have reported COGS in the 45-55% range in recent quarters. Section 280E of the Internal Revenue Code significantly impacts cannabis COGS calculations for U.S. companies. This federal tax provision prohibits deducting most business expenses for federally illegal substances, making COGS the primary deductible expense category. This creates substantial tax burdens, with effective tax rates often exceeding 40-60% for profitable cannabis operators. Investors closely monitor COGS trends as an indicator of operational efficiency and scalability. Declining COGS as a percentage of revenue typically signals improving cultivation yields, automation benefits, or economies of scale. However, factors like new market entry, facility expansions, or increased testing requirements can temporarily elevate COGS. Disclaimer: This information is for educational purposes only and should not be considered investment advice. Cannabis investors should consult financial professionals and review company filings for complete financial analysis.